FRIER LEVITT GOES RED FOR WOMEN’S HEART HEALTH:
Frier Levitt’s attorneys and staff share photos of themselves wearing red for the American Heart Association’s “Go Red Day” to help earn money for the organization to fight heart disease.
Frier Levitt of Pine Brook continued its “20 Charitable Acts for 20 Years” initiative in last month when members of the firm, both virtual and in the office, wore red to support the American Heart Association’s “Go Red for Women.” On Feb. 5, Frier Levitt members wore red on National Wear Red Day, to spread awareness that one in three women die from cardiovascular disease. The firm committed to donate funds for each of its employees who wore red, and their efforts netted a $350 donation from the firm to the American Heart Association, the announcement said. “Go Red for Women” seeks to increase women’s heart health awareness and improve the lives of women globally. For 17 years, the movement has encouraged awareness.
Faegre Drinker Sponsors Pharmaceutical Litigation CLE
Michael Zogby
Faegre Drinker Biddle & Reath was a sponsor of the American Bar Association Litigation Section’s “Current Issues in Pharmaceutical, Medical Device and Biotech Litigation Virtual Regional CLE Program,” held virtually on Feb. 25-26, 2021. The two-day event featured programming addressing current and developing issues in pharmaceutical, medical device and biotech litigation. Faegre Drinker products liability and mass torts practice deputy leader Michael Zogby was one of the program organizers and is co-chair of the ABA Mass Torts Litigation Committee’s Pharmaceutical and Medical Device Subcommittee. Zogby, a partner in the firm’s Florham Park office, moderated “Inside View: Legal and Ethical Considerations for In-House Counsel,” a corporate roundtable panel discussion addressing the legal and ethical challenges and trends faced by in-house attorneys at pharmaceutical, biotech and medical device companies in the midst of a global pandemic. Panelists included inside counsel from Eli Lilly, Daiichi Sankyo, Novo Nordisk and Johnson & Johnson.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
